Fundraising Fox
/People
Sign in

Kjell Mortier

Former Fund Manager at Novalis Biotech

Ghent Metropolitan Area

Find your path to Kjell

237 people in our graph can introduce you to Kjell.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Jan Van den Berghe to introduce you to Kjell

You →Jan · together at Epify BV (2019–2023) →Kjell

Ask Jamie Chen to introduce you to Kjell

You →Jamie · 3 people · together at Novalis Biotech →Kjell

Ask Sam Okafor to introduce you to Kjell

You →Sam · together at Waters →Kjell

Sign up to find every way you can get introduced to Kjell

  • Your email: the people you already email who know Kjell
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Kjell
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Kjell Mortier (Pharm., PhD) is a Fund Manager at Novalis. He has around 20 years of experience in the biotech industry across scientific roles in large pharma and CDMO companies, including work on bioanalytical and immunogenicity aspects of (pre-)clinical programs at Ablynx (now part of Sanofi) and CMC-analytical support and technology evaluation at the CRO Eurofins. He also holds a certification in financial analysis from EHSAL Management School.

Contact· self-published, not guessed

Invests in

Biotech

Experience

  1. Mobio ConsultOwner and managing directorcurrent2019 — present
  2. CLOUDS OF CAREBoard Observer2025 — 2026Belgium
  3. BioLizardBoard Member2021 — 2026Ghent
  4. Novalis BiotechFund Manager2019 — 2026
  5. RheumaFinderBoard Member2023 — 2026
  6. RheaVita BVBABoard Member2021 — 2026
  7. Epify BVBoard Member2019 — 2024
  8. BioLizardInterim Manager2019 — 2020Ghent, Belgium
  9. Eurofins Amatsigroup (CDMO)Principal Scientist Analytics2016 — 2019Gent Area, Belgium
  10. AblynxScientist2011 — 2016Zwijnaarde, Belgium
  11. AnaBioTecProject leader2010 — 2011Zwijnaarde, Belgium
  12. Baxter BioScienceContinuous Improvement Supervisor QC Lab2009 — 2010Lessines, Belgium
  13. WatersLC-MS application specialist2006 — 2009Zellik, Belgium
  14. Ghent University - Faculty of Pharmaceutical Sciences - ToxicologyPhD2000 — 2006

Skills & more

Mass Spectrometry6LC-MS8HPLC2Chromatography7Proteomics2GLP3GMP2ELISA1Chemistry2Bioanalysis5Validation2Pharmacology3
+4 moreGas ChromatographyFDALife SciencesGood Laboratory Practice (GLP)

From Kjell's professional profile.

Frequently asked questions

Who is Kjell Mortier?
Kjell Mortier (Pharm., PhD) is a Fund Manager at Novalis. He has around 20 years of experience in the biotech industry across scientific roles in large pharma and CDMO companies, including work on bioanalytical and immunogenicity aspects of (pre-)clinical programs at Ablynx (now part of Sanofi) and CMC-analytical support and technology evaluation at the CRO Eurofins. He also holds a certification in financial analysis from EHSAL Management School.
What does Kjell Mortier invest in?
Kjell Mortier invests in Biotech.
Where did Kjell Mortier go to school?
Kjell Mortier studied at Guberna - Instituut voor Bestuurders (Board Effectiveness); Guberna - Instituut voor Bestuurders (Director Effectiveness); Vlerick Business School (Venture Capital and Private Equity).

Same school

Shared employers